What Is a Stakeholder in Public Health?

A stakeholder in public health is any person, group, or organization that affects or is affected by a public health decision, program, or policy. That definition is deliberately broad. It sweeps in government agencies writing regulations, community members living with the health problem, hospitals delivering care, businesses whose products shape health outcomes, researchers generating evidence, and advocacy groups pushing for change. One widely used framework organizes these players into seven main categories: the public, policymakers and governments, the research community, practitioners and professionals, health and social service providers, civil society organizations, and private business.

The Seven Categories and Who Falls Where

A study developing a stakeholder framework for health research identified those seven umbrella groups, each with detailed sub-groups underneath.¹ “The public” includes patients, caregivers, healthy community members, and anyone whose daily life is touched by the issue at hand. “Policymakers and governments” spans everyone from local council members to national legislators to international bodies. “Practitioners and professionals” covers clinicians, social workers, urban planners, educators, and others whose professional work intersects with health. Civil society organizations include nonprofits, faith-based groups, and advocacy coalitions. Private business ranges from pharmaceutical companies to food manufacturers to technology firms.

A separate taxonomy designed for patient-centered outcomes research, called the 7Ps of Stakeholder Engagement, offers another way to slice the same pie, mapping stakeholders across six stages of the research process rather than by sector alone.² The point of both frameworks is the same: public health decisions ripple outward, and the people caught in those ripples deserve a seat at the table.

Why Public Health Moved Toward Stakeholder Engagement

Public health decision-making was not always this inclusive. In the United States, the risk assessment and risk management paradigm that underpins federal decisions about environmental health risks was first established in 1983. At that point, public participation was barely acknowledged. Experts made decisions behind closed doors, and the public was informed after the fact.³ Over the following decades, it became clear that environmental and health problems were more complicated, more controversial, and more expensive to solve than anyone had assumed. Meaningful engagement shifted from a peripheral concern to something built into every phase of decision-making, because it promotes buy-in from the people affected, taps into knowledge that experts alone do not possess, and supports what some scholars call environmental democracy.

That trajectory was not unique to the United States. Canadian primary health care researchers, for instance, have been actively engaging patients and other stakeholders over the past several years, anticipating and strengthening what has become a broader shift in how health research gets done.⁴ The trend is global, though its pace and depth vary enormously from one country to the next.

Community Members and Grassroots Organizations

Of all the stakeholder groups, community members are often the hardest to engage effectively and the most transformative when engagement works. A systematic review of community engagement in public health interventions found three overarching models that consistently produced results: peer-led delivery, where community members themselves carry the intervention; varying degrees of collaboration between communities and health services; and approaches built on empowerment philosophies that shift real decision-making power to residents.⁵

Community-based participatory research, or CBPR, has become one of the best-known approaches for structuring this kind of work. It equitably involves community members, researchers, and other stakeholders in the research process and recognizes that each group brings distinct strengths.⁶ CBPR has been described as a transformative paradigm that bridges the gap between science and practice through community engagement and social action, with a particular focus on increasing health equity.⁷ The emphasis on redressing power imbalances between academic and community partners is not incidental; it is central to the model.

A concrete example comes from Greenville County, South Carolina, where a group of 19 multi-sector stakeholders from an existing coalition used a theory-informed, stakeholder-driven intervention to tackle childhood obesity. The process led to three new priority areas: addressing food insecurity, building power among historically marginalized voices, and supporting advocacy for community-wide change that went beyond the coalition’s original focus on organizational-level policy.⁸ The intervention also spread to partner organizations working on other health issues, suggesting that when stakeholder-driven approaches succeed, they can shift how an entire community thinks about complex problems.

Government and Regulatory Stakeholders

Governments at every level are among the most powerful stakeholders in public health. Local governments set zoning rules that shape whether neighborhoods have sidewalks or fast-food clusters. State and national agencies write the regulations that determine air quality standards, food safety rules, and vaccination schedules. International bodies set norms that filter down into national policy.

Research on Australian local governments found that several external factors support their ability to address health inequities: strong community support, state government leadership and legislation, and supportive local partners, networks, and NGOs.⁹ In other words, government stakeholders do not operate in isolation. Their effectiveness depends on relationships with the other categories of stakeholders, including the communities they serve.

Healthcare providers and health system administrators also occupy a critical bridging role. They sit at the intersection of clinical care and public health interventions, facilitating the translation of research into practice and helping address local health priorities.¹⁰ A hospital system that tracks emergency-room visits for asthma, for example, generates data that can shape air quality policy if the right stakeholder connections exist.

The Private Sector and Its Tensions

Businesses are public health stakeholders whether anyone invites them to be or not. Food companies shape diets. Employers set working conditions. Pharmaceutical firms develop treatments. Technology companies build the digital infrastructure people use to access health information. Engaging with the private sector can bring resources and create opportunities to nudge corporate behavior toward healthier practices. But the relationship is inherently fraught.

A review of cross-sector partnerships focused on obesity and noncommunicable diseases identified goal alignment and conflict of interest as key challenges.¹¹ A soda company funding a nutrition education program, for instance, has financial incentives that run counter to the program’s public health goals. Even when partnerships are well-intentioned, the risk of corporate actors using the relationship to burnish their image or delay regulation is real.

At the global level, the WHO Foundation was created during the COVID-19 pandemic to widen the World Health Organization’s resource base by attracting philanthropic donations from the commercial sector. The idea was to place funding decisions at arm’s length from WHO itself, insulating the organization from conflicts of interest and reputational risk.¹² Whether that structural distance actually works as intended remains an open and debated question.

How Stakeholders Get Identified and Mapped

Figuring out who your stakeholders are sounds straightforward, but in practice it is one of the trickiest parts of any public health initiative. A common approach is the power-interest grid, which plots stakeholders along two axes: how much power they have to influence the outcome and how much interest they have in it. A health technology assessment of COVID-19 vaccination in Nigeria used this framework as part of a three-step process: informal discussions with key players, formal stakeholder mapping and analysis, and communication strategies for getting evidence into the right hands.¹³

A more rigorous approach was used in Ethiopia, where researchers conducted a modified Delphi process with 35 public health experts to rate stakeholders across five criteria: importance, influence, involvement, engagement quality, and resource contribution.¹⁴ The method produced a more systematic picture than informal brainstorming alone, though it still depended on who was invited to participate in the expert panel. That is a recurring limitation: stakeholder mapping exercises tend to identify the stakeholders who are already visible and connected, while missing those who are marginalized or unfamiliar to the mapping team.

Power Imbalances and Who Gets Left Out

The gap between who should be a stakeholder and who actually gets heard is one of the most persistent problems in public health. A qualitative study in Malawi found that there had been no significant strengthening of stakeholder engagement in the country’s centralized policy development process, and that the only publicly available government-sanctioned engagement plan had been developed by the World Bank together with the government rather than arising from domestic initiative.¹⁵ The pattern of donors asserting the value of engagement on behalf of governments is not unique to Malawi, and it raises uncomfortable questions about whose priorities drive the process.

Power dynamics operate at multiple levels. A conceptual framework for participatory health research situates these dynamics within a system of bidirectional connections at the individual, interpersonal, and structural levels.¹⁶ A community member may have relevant lived experience but lack the professional credentials to be taken seriously in a policy meeting. A researcher may hold institutional power that subtly shapes which questions get asked and which do not. A government official may control funding in ways that make other stakeholders reluctant to criticize.

An intersectional approach to stakeholder engagement has been proposed to address these layered inequities. The argument is that inclusive, intentional, and mutually respectful engagement requires accounting for the overlapping and compounding impacts of multiple systems of power on the lived experiences of priority populations.¹⁷ In practical terms, this means recognizing that a low-income Indigenous woman with a disability faces a different set of barriers to participation than a middle-class white man, and that engagement strategies need to be designed with those differences in mind rather than treating “the community” as a monolith.

Conflicts of Interest Are Built Into the System

Because stakeholders are, by definition, people or groups with a stake in the outcome, conflicts of interest are not a bug but a feature of the engagement process. A systematic review protocol examining conflicts of interest in health guideline development noted that patient representatives at U.S. Food and Drug Administration regulatory processes have been found to have personal conflicts of interest stemming from fees received from industry, as well as conflicts arising from their organizations’ ties to pharmaceutical companies. An observational study of over 700 U.S. journal editors found that about half received general payments from industry in a single year.¹⁸

None of this means stakeholder engagement should be abandoned. It means the process needs transparency mechanisms: disclosure requirements, clear governance structures, and independent oversight. The challenge is that the stakeholders with the most resources to participate, like industry groups, often have the most pronounced conflicts, while the stakeholders with the fewest conflicts, like unaffiliated community members, often have the fewest resources to show up and stay involved.

Stakeholders During Health Emergencies

Health emergencies compress time and amplify the consequences of poor stakeholder coordination. A synthesis of COVID-19 pandemic preparedness and response plans from 70 countries found that just under half included inter-sectoral and inter-ministerial coordination strategies such as ad-hoc task forces. Most plans identified central government, usually the Ministry of Health, as the key stakeholder that should lead implementation.¹⁹ But the level of detail about who else should be involved and what their roles would be varied dramatically.

Palestine offers a cautionary example. A qualitative study of public health emergency preparedness found that no national entity or mechanism was leading collective preparedness efforts. Instead, efforts were dispersed across several entities, decisions were not made cooperatively, and no emergency budget had been allocated.²⁰ There was some multi-sectoral collaboration, but concerns about the proliferation of committees and their actual effectiveness in handling crises tempered any optimism. The lesson is consistent across settings: listing stakeholders on paper is easy; making sure they can coordinate under pressure is far harder.

Researchers as Stakeholders

Academics occupy a peculiar position in the stakeholder landscape. Their main role is generating evidence, but the priorities of academic institutions do not always align with the priorities of the communities they study. Research on knowledge translation in Uganda found that researchers focusing disproportionately on academic interests rather than policy-relevant questions was a widely cited concern among other stakeholders.²¹ A study designed to produce a high-impact journal publication may ask a different question than one designed to solve a pressing local problem, and researchers face career incentives that reward the former over the latter.

This tension does not make researchers bad stakeholders. It makes them stakeholders with a specific set of interests, just like everyone else. The fix is not to exclude them but to ensure that the research agenda is shaped collaboratively, with community and policy stakeholders helping to define what questions matter most.

Measuring Whether Engagement Actually Works

One of the weakest links in the stakeholder engagement chain is evaluation. Everyone agrees that engagement is important, but measuring whether it leads to better health outcomes is genuinely difficult. Some initiatives have built evaluation into the process from the start. A regional stakeholder engagement effort in physical activity research created an evaluation plan early on, tracking both the reach of the event and stakeholder satisfaction through post-meeting surveys.²² Satisfaction surveys are a reasonable starting point, but they measure whether people felt heard, not whether the engagement changed outcomes.

More sophisticated approaches exist. A systematic review examining community participation in health service coverage used a framework synthesis to assess effectiveness across dimensions including equity, depth of engagement, and the stage at which stakeholders were involved.²³ Meanwhile, a study of public health engagement in alcohol licensing in England and Scotland developed a 19-item measure across six categories, tracking activities like staffing, reviewing license applications, data usage, and public involvement. The scores showed that both the type and level of engagement fluctuated over time and across areas.²⁴ That fluctuation is itself a finding: stakeholder engagement is not a one-time box to check but an ongoing process that waxes and wanes depending on resources, political will, and competing priorities.

Social Media Influencers as an Emerging Stakeholder Group

The stakeholder landscape is not static. One of the more striking recent additions is social media influencers, who have become an increasingly influential voice in public discourse around health. Public health entities are embracing influencers as potential health promotion collaborators, recognizing that a creator with a large following can reach populations that traditional public health messaging misses entirely.²⁵

The appeal is obvious: influencers speak the language of their audiences in ways that government agencies and academic researchers typically do not. But the arrangement also introduces new complications. Influencers are not bound by the ethical codes that govern healthcare professionals. Their content is shaped by platform algorithms that reward engagement over accuracy. And the line between genuine health communication and sponsored content can be invisible to followers. Whether influencers evolve into a durable and trustworthy stakeholder group or remain a risky shortcut for public health messaging will depend on how seriously the field takes the task of building transparent, accountable partnerships with them.